Stage IIA Prostate Cancer AJCC v7
specificStage IIA includes: (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X). T1a: Tumor incidental histologic finding in 5% or less of tissue resected. T1b: Tumor incidental histologic finding in more than 5% of tissue resected. T1c: Tumor identified by needl
17
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Stage IIA Prostate Cancer AJCC v7(17)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 56.9 |
| 2 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 56.9 |
| 3 | NCI Comprehensive Active Research Program | 56.9 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 56.9 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.9 |
| 6 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 56.9 |
| 7 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 56.9 |
| 8 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 56.9 |
| 9 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 56.9 |
| 10 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.9 |
| 11 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 56.9 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 56.9 |
| 13 | Cancer Center at IllinoisUrbana, IL Active Research Program | 56.9 |
| 14 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 56.9 |
| 15 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 34.4 |
| 16 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 34.4 |
| 17 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 34.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →